OBJECTIVE: The aim of this study was to evaluate ovarian reserve of women with type 2 diabetes mellitus (T2DM). METHODOLOGY: Eighty-nine women with T2DM and 73 healthy controls were enrolled and divided into three age groups [group 1 (20-29 yr), seven diabetics and 18 healthy controls; group 2 (30-39 yr): 35 diabetics and 35 healthy controls; and group 3 (40-49 yr): 47 diabetics and 20 healthy controls]. All participants were subjected to transvaginal ultrasonographic examination on the third day of their menstrual periods for the determination of ovarian volume and total antral follicle count (AFC). RESULTS: A significant difference in mean FSH levels (international units per liter) was observed between women with diabetes and healthy controls in all age groups (group 1, 7.8 ± 0.9 vs. 5.0 ± 1.0; group 2, 8.2 ± 1.1 vs. 7.2 ± 1.8; group 3, 9.5 ± 3.2 vs. 6.4 ± 2.4; P < 0.001 for all). Similarly, mean AFC was significantly lower in patients with T2DM than in healthy controls in all age groups (group 1, 21.1 ± 4.8 vs. 25.0 ± 9.1; group 2, 10.4 ± 5.2 vs. 23.0 ± 9.5; group 3, 6.0 ± 3.5 vs. 21.7 ± 2.1; P < 0.001 for all). A statistically significant difference in total ovarian volume was only observed in group 1 (9.7 ± 3.0 in T2DM patients vs. 6.8 ± 2.7 in healthy controls; P = 0.002). AFC was found to be negatively correlated with FSH (r = -0.406, P < 0.001), age (r = -0.618, P < 0.001), glycolized hemoglobin (r = -0.505, P < 0.001), and fasting blood glucose (r = -0.687, P < 0.001). CONCLUSION: In this pioneer study, the first to evaluate ovarian reserve in T2DM patients, we managed to demonstrate lower ovarian reserves in women with diabetes compared with healthy controls.
OBJECTIVE: The aim of this study was to evaluate ovarian reserve of women with type 2 diabetes mellitus (T2DM). METHODOLOGY: Eighty-nine women with T2DM and 73 healthy controls were enrolled and divided into three age groups [group 1 (20-29 yr), seven diabetics and 18 healthy controls; group 2 (30-39 yr): 35 diabetics and 35 healthy controls; and group 3 (40-49 yr): 47 diabetics and 20 healthy controls]. All participants were subjected to transvaginal ultrasonographic examination on the third day of their menstrual periods for the determination of ovarian volume and total antral follicle count (AFC). RESULTS: A significant difference in mean FSH levels (international units per liter) was observed between women with diabetes and healthy controls in all age groups (group 1, 7.8 ± 0.9 vs. 5.0 ± 1.0; group 2, 8.2 ± 1.1 vs. 7.2 ± 1.8; group 3, 9.5 ± 3.2 vs. 6.4 ± 2.4; P < 0.001 for all). Similarly, mean AFC was significantly lower in patients with T2DM than in healthy controls in all age groups (group 1, 21.1 ± 4.8 vs. 25.0 ± 9.1; group 2, 10.4 ± 5.2 vs. 23.0 ± 9.5; group 3, 6.0 ± 3.5 vs. 21.7 ± 2.1; P < 0.001 for all). A statistically significant difference in total ovarian volume was only observed in group 1 (9.7 ± 3.0 in T2DM patients vs. 6.8 ± 2.7 in healthy controls; P = 0.002). AFC was found to be negatively correlated with FSH (r = -0.406, P < 0.001), age (r = -0.618, P < 0.001), glycolized hemoglobin (r = -0.505, P < 0.001), and fasting blood glucose (r = -0.687, P < 0.001). CONCLUSION: In this pioneer study, the first to evaluate ovarian reserve in T2DM patients, we managed to demonstrate lower ovarian reserves in women with diabetes compared with healthy controls.
Authors: Catherine Kim; Carrie Karvonen-Gutierrez; Shengchun Kong; Valerie Arends; Michael Steffes; Daniel S McConnell; John F Randolph; Siobán D Harlow Journal: Fertil Steril Date: 2016-07-28 Impact factor: 7.329
Authors: J S Brand; N C Onland-Moret; M J C Eijkemans; A Tjønneland; N Roswall; K Overvad; G Fagherazzi; F Clavel-Chapelon; L Dossus; A Lukanova; V Grote; M M Bergmann; H Boeing; A Trichopoulou; M Tzivoglou; D Trichopoulos; S Grioni; A Mattiello; G Masala; R Tumino; P Vineis; H B Bueno-de-Mesquita; E Weiderpass; M L Redondo; M J Sánchez; J M Huerta Castaño; L Arriola; E Ardanaz; E J Duell; O Rolandsson; P W Franks; S Butt; P Nilsson; K T Khaw; N Wareham; R Travis; I Romieu; M J Gunter; E Riboli; Y T van der Schouw Journal: Hum Reprod Date: 2015-03-15 Impact factor: 6.918
Authors: Yan Yi; Samar R El Khoudary; Jeanine M Buchanich; Rachel G Miller; Debra Rubinstein; Trevor J Orchard; Tina Costacou Journal: Menopause Date: 2021-04-05 Impact factor: 2.953
Authors: Laura S Girão Lopes; Rubens Prado Schwartz; Bruno Ferraz-de-Souza; Maria Elizabeth Rossi da Silva; Pedro Henrique Silveira Corrêa; Márcia Nery Journal: Diabetol Metab Syndr Date: 2015-02-27 Impact factor: 3.320
Authors: Catherine Kim; Patricia A Cleary; Catherine C Cowie; Barbara H Braffett; Rodney L Dunn; Mary E Larkin; Patricia M Gatcomb; Hunter B Wessells; David M Nathan; Aruna V Sarma Journal: Diabetes Care Date: 2013-10-29 Impact factor: 19.112